Berlin-based Amboss, a knowledge platform for medical professionals, raises €30M Series B led by Partech's growth fund
Amboss, the Berlin-based ‘medtech’ startup that originally offered a learning app for students but has since pivoted to a knowledge platform for medical professionals …
Context & Ripple Effects
Amboss started as a study app for medical students, and this €30M Series B led by Partech's growth fund marks its push to become a knowledge platform serving practicing clinicians — a wider, more monetizable user base than exam prep alone. It lands in a Berlin digital-health cluster that has been funding up steadily: Ada Health raised $47M back in 2017 and followed with a $90M Series B led by Leaps by Bayer in 2021, while Meditopia, Temedica, and Patient21 each pulled in eight-figure rounds across the same window.
The round also reads, in hindsight, as an early checkpoint on a much larger trajectory: by March 2025 Amboss had reportedly raised €240M at a valuation above €800M, making this 2019 raise the step where the student-to-clinician pivot first got serious institutional backing.
First-order effects
- Partech's growth fund becomes Amboss's lead backer, giving the company capital to expand content and tooling beyond medical students to practicing clinicians — shifting its revenue base toward professional subscriptions.
- Amboss joins Berlin's funded digital-health cohort alongside Ada Health and Meditopia, raising the city's profile as a hub for clinician- and patient-facing health software.
Second-order effects
- Rivals in medical education and clinical reference must respond to a better-capitalized Amboss, since sustained Series B spending on content depth and product raises the bar for subscription knowledge platforms serving doctors.
- Growth-stage investors watching Partech's bet get a comparable template in Berlin health tech, feeding follow-on interest in adjacent players like Temedica's pharma-data play and Patient21's clinic-plus-platform model.
Third-order effects
- If the pattern holds, European medical-knowledge platforms consolidate around a few scaled subscription businesses that serve professionals across their whole careers — from student through practicing clinician — rather than point solutions for one stage.
- Berlin's cluster effect compounds: successive large rounds for Amboss, Ada Health, and peers make the city a default place for growth capital seeking health software, shaping where European medtech talent and founders concentrate.
The trend: Berlin digital-health startups are graduating from student- and consumer-facing apps into clinician-grade knowledge platforms, with round sizes scaling accordingly.